跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
格拉诺赛特 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Recombinant Human Granulocyte Colony-stimulating Factor for Injection(CHO cell)
Approved
生物制品
Recombinant Human Granulocyte Colony-stimulating Factor for Injection(CHO cell)
CHUGAI PHARMACEUTICAL CO., LTD.
🇨🇳 National Medical Products Administration
Approval Date
Sep 16, 2019
Approval ID
7MazXbGUMAC
Company
CHUGAI PHARMACEUTICAL CO., LTD.
Type
生物制品
Approval Details
Approval Id
7MazXbGUMAC
Approval Number
S20140021
Generic Name
注射用重组人粒细胞刺激因子(CHO细胞)
Generic Name En
Recombinant Human Granulocyte Colony-stimulating Factor for Injection(CHO cell)
Trade Name
格拉诺赛特
Brand Name
格拉诺赛特
Drug Type
生物制品
Dosage Form
注射剂
Strength
250μg/支
Reg Date
2019-09-16
Expired Date
2024-09-15
Company Name
CHUGAI PHARMACEUTICAL CO., LTD.
Company Address
5-1, Ukima 5-Chome, Kita-ku, Tokyo Japan
Production Company Name
utsunomiya plant of chugai pharma manufacturing co.,ltd
Production Company Address
16-3, Kiyohara Kougyoudanchi, Utsunomiya-city, Tochigi, Japan
Company Detail Path
/organization/chugai-pharmaceutical-co-ltd
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Sep 16, 2019
Approval ID
7MazXbGUMAC
Type
生物制品
Back to NMPA Approvals